Micafungin
Phase 1Completed 3 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Fungal Infections
Conditions
Fungal Infections
Trial Timeline
Nov 1, 2007 → Mar 1, 2009
NCT ID
NCT00606268About Micafungin
Micafungin is a phase 1 stage product being developed by Astellas Pharma for Fungal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT00606268. Target conditions include Fungal Infections.
What happened to similar drugs?
9 of 20 similar drugs in Fungal Infections were approved
Approved (9) Terminated (3) Active (10)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (15)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03174457 | Pre-clinical | Completed |
| NCT03102658 | Approved | Completed |
| NCT02440178 | Phase 2 | Completed |
| NCT03421002 | Phase 2 | Completed |
| NCT02678598 | Pre-clinical | Completed |
| NCT02127788 | Pre-clinical | Completed |
| NCT02646800 | Approved | Terminated |
| NCT02646774 | Approved | Terminated |
| NCT02057289 | Phase 1 | Terminated |
| NCT01982071 | Approved | Terminated |
| NCT01135589 | Approved | UNKNOWN |
| NCT00606268 | Phase 1 | Completed |
| NCT00608335 | Phase 1 | Completed |
| NCT00818584 | Phase 1 | Completed |
| NCT00842504 | Phase 1 | Completed |
Competing Products
20 competing products in Fungal Infections